selected publications
-
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
Oncogene.
2023
Academic Article
GET IT
Times cited: 31 -
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors.
The oncologist.
2018
Academic Article
GET IT
Times cited: 33 -
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2015
Academic Article
GET IT
Times cited: 238 -
Venous thromboembolism in patients with diffuse large B-cell lymphoma.
Leukemia & lymphoma.
2006
Academic Article
GET IT
Times cited: 68